In patients with MASLD, precancerous lesions were positively associated with age and male gender, while negatively associated with advanced fibrosis.

Patients with gastroesophageal reflux disease are at increased risk of developing lung cancer, according to a study presented at DDW 2025.

Black patients face higher complications related to inflammatory bowel disease than White patients, according to a study presented at DDW 2025.

In patients with IBD on maintenance IFX, use of 5-ASA and immunomodulators does not significantly reduce flares, infections, or adverse reactions.

In biologic-naive patients with CD, there were no differences in clinical remission or disease progression between those who received risankizumab vs ustekinumab.

Fall history, sodium-glucose cotransporter 2 inhibitor use, and age were independent fall predictors. HealthDay News — Sodium-glucose cotransporter 2 (SGLT2) inhibitor use is an independent risk ...

US health officials directed food companies to voluntarily phase out petroleum-based synthetic dyes by the end of 2026. HealthDay News — The push to remove artificial colors from U.S. foods is gaining ...

Proportion of adult managed care organizations with access to cardioprotective medications varied from 24 to 100% for SGLT2 inhibitors and 0 to 99% for GLP-1 receptor agonists. HealthDay News — Many ...

The TRIUMpH studies met all primary and secondary endpoints. Topline data were announced from two phase 3 studies evaluating tegoprazan in patients with gastroesophageal reflux disease (GERD). The ...

A new study reveals that many perceived benefits of gluten-free products, such as weight control and diabetes management, are ...

The HHS and FDA have released further details of their plans to remove all petroleum-based synthetic dyes from the nation's food supply.